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Heat shock protein 60s (hsp60) are remarkably immunogenic, and both T-cell and antibody responses to
hsp60 have been reported in various inflammatory conditions. To clarify the role of hsp60 in T-cell responses
in periodontitis, we examined the proliferative response of peripheral blood mononuclear cells (PBMC), as well
as the cytokine profile and T-cell clonality, for periodontitis patients and controls following stimulation with
recombinant human hsp60 and Porphyromonas gingivalis GroEL. To confirm the infiltration of hsp60-reactive
T-cell clones into periodontitis lesions, nucleotide sequences within complementarity-determining region 3 of
the T-cell receptor (TCR) -chain were compared between hsp60-reactive peripheral blood T cells and
periodontitis lesion-infiltrating T cells. Periodontitis patients demonstrated significantly higher proliferative
responses of PBMC to human hsp60, but not to P. gingivalis GroEL, than control subjects. The response was
inhibited by anti-major histocompatibility complex class II antibodies. Analysis of the nucleotide sequences of
the TCR demonstrated that human hsp60-reactive T-cell clones and periodontitis lesion-infiltrating T cells
have the same receptors, suggesting that hsp60-reactive T cells accumulate in periodontitis lesions. Analysis
of the cytokine profile demonstrated that hsp60-reactive PBMC produced significant levels of gamma inter-
feron (IFN-) in periodontitis patients, whereas P. gingivalis GroEL did not induce any skewing toward a type1
or type2 cytokine profile. In control subjects no significant expression of IFN- or interleukin 4 was induced.
These results suggest that periodontitis patients have human hsp60-reactive T cells with a type 1 cytokine
profile in their peripheral blood T-cell pools.
Periodontitis is a chronic inflammatory disease character-
ized by mononuclear cell infiltration into the gingival tissues,
leading to connective tissue destruction and alveolar bone re-
sorption. Although periodontal bacteria are the causative
agents in periodontitis, subsequent progression and disease
severity are thought to be determined by the host immune
responses (28). The precise mechanisms of tissue destruction,
however, have not been fully elucidated; nevertheless, a num-
ber of reports have implicated autoimmune responses in the
disease process (2, 5, 12).
Collagen type 1, a major component of the periodontium,
has been considered to be one of the target antigens of this
autoimmune response due to the fact that high titers of anti-
collagen type I antibody are found in the sera (12), and that
collagen type I-specific T-cell clones can be identified in the
inflamed gingival tissues, of periodontitis patients (38). Heat
shock protein 60 (hsp60) has also been suggested as another
important candidate antigen. hsp60 belongs to a family of
related proteins which have been conserved during evolution.
Despite being highly homologous between prokaryotic and
eukaryotic cells, hsp60s are strongly immunogenic, and im-
mune responses to microbial hsp60s are speculated to initiate
chronic inflammatory diseases in which autoimmune responses
to human hsp 60 may be central to pathogenesis (16). Major
periodontopathic bacteria such as Porphyromonas gingivalis
(13, 19), Actinobacillus actinomycetemcomitans (21), Fusobac-
terium nucleatum (37), Prevotella intermedia (37), Bacteroides
forsythus (37), and Campylobacter rectus (11) are reported to
produce hsp’s homologous to Escherichia coli GroEL. We have
previously demonstrated that the frequency of seropositivity
and titers of antibodies to human hsp60 and P. gingivalis
GroEL were significantly higher in periodontitis patients than
in periodontally healthy control subjects (29). Furthermore,
affinity-purified serum antibodies to human hsp60 and P. gin-
givalis GroEL cross-reacted with P. gingivalis GroEL and hu-
man hsp60, respectively. These results suggest that an immune
response based on the molecular mimicry between P. gingivalis
GroEL and human hsp60 may play a role in periodontitis.
hsp60 has been reported as the dominant microbial antigen
for T cells, and in fact, T cells with specificity for mycobacterial
hsp60 have been identified in both the human (20) and murine
(15) systems. The concept that hsp60 is a dominant antigen in
mycobacterial infection has led to the suggestion that hsp’s are
abundantly produced by the bacteria in order to enhance sur-
vival inside the host macrophages and so avoid attack by toxic
molecules (42). It has also been reported that self-hsp60 can be
recognized by T cells specific for mycobacterial hsp60, suggest-
ing the presence of T cells with specificity for cross-reactive
epitopes (20). However, periodontopathic bacteria usually col-
onize and proliferate extracellularly, and T-cell responses in
periodontitis have not been clarified in the context of molec-
ular mimicry between human and periodontopathic bacterial
hsp60s.
In order to gain further insight into the role of hsp60 and
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hsp60-reactive T cells, we investigated the proliferative re-
sponses of peripheral blood mononuclear cells (PBMC) from
patients with severe periodontitis and from healthy control
subjects to bacterial and human hsp60s. Further, the presence
of reactive T-cell clones to hsp60 in periodontitis lesions was
examined by determining the nucleotide sequences within
complementarity-determining region 3 (CDR3) region of the
T-cell receptor (TCR) -chain of hsp60-reactive T-cell clones
and comparing them with those of T cells infiltrating the pe-
riodontitis lesion. Because the cytokine profile of the reactive
T-cell clones is important in determining the type of response,
we also analyzed gamma interferon (IFN-) and interleukin-4
(IL-4) at both the mRNA and protein levels following stimu-
lation with hsp60s.
MATERIALS AND METHODS
Subjects and specimen collection. Gingival tissue samples were obtained at the
time of periodontal surgery (flap surgery) from 16 patients with moderate to
severe periodontitis (mean age, 40.4  9.9 years; range, 26 to 55 years) referred
to the periodontal clinic of Niigata University Dental Hospital. All patients were
classified as having chronic periodontitis with no systemic disorders. The mean
probing depth, probing attachment level, and radiographic bone resorption were
6.5  1.4 mm (range, 4 to 9 mm), 7.5  1.7 mm (range, 4 to 10 mm) and 58.2 
27.1% (range, 10 to 100%), respectively. Alveolar bone resorption was measured
on the proximal surface of each tooth on a radiograph. The distances from the
cemento-enamel junction (CEJ) and alveolar bone ledge (ABL) to the root apex
(RA) were measured. Alveolar bone resorption, expressed as percent bone loss,
was calculated as (CEJ-to-ABL distance)/(CEJ-to-RA distance)  100 (26).
Informed consent was obtained from all patients before inclusion in the study.
Gingival tissue from each specimen was immediately frozen in liquid nitrogen
and stored at 80°C until RNA separation. PBMC were separated by Ficoll-
Paque (Pharmacia Fine Chemicals, Piscataway, N.J.) density gradient centrifu-
gation from 20 to 30 ml of autologous peripheral blood. PBMC were also
separated from 10 periodontally healthy subjects (mean age, 38.0  7.7 years;
range, 30 to 49 years) with probing attachment levels of 4 mm and minimal
bone resorption at all sites.
Cell culture and proliferation assay. PBMC were suspended in RPMI 1640
(GIBCO BRL, Grand Island, N.Y.) supplemented with 10% human AB serum
(C-Six Diagnostics, Inc., Mequon, Wis.), 20 mM HEPES buffer (GIBCO BRL),
100 U of penicillin/ml, 100 g of streptomycin (GIBCO BRL)/ml, 2 mM glu-
tamine (GIBCO BRL), and 5  105 M 2-mercaptoethanol. To determine the
optimal concentrations of the recombinant human hsp60 (StressGen Biotech-
nologies Corp., Victoria, British Columbia, Canada) and P. gingivalis GroEL, the
latter was prepared as described previously (29), and cells were cultured at
concentrations of 3  105/well in a 96-well culture plate (Nunc, Roskilde, Den-
mark) and stimulated with various doses of hsp60 and P. gingivalis GroEL (0.1 to
10 g/ml) for 6 days in a humidified atmosphere of 5% CO2 in air at 37°C. For
subsequent experiments, a dose of 10 g/ml was used, because the response at
this dose was maximal. Cultures were pulsed for the last 18 h with 0.5 Ci of
[3H]thymidine/well. Cells were harvested onto glass fiber filters by a cell har-
vester (Lab Science, Tokyo, Japan), and [3H]thymidine incorporation was mea-
sured by a liquid scintillation counter (Packard Instrument Co., Downers Grove,
Ill.)
Determination of major histocompatibility complex (MHC) restriction of T-
cell proliferation. Inhibition of proliferative responses of PBMC stimulated with
human hsp60 was examined by using monoclonal antibodies to human HLA-DP
(clone BraFB6, IgG2b), HLA-DQ (clone SPV-L3, IgG2a), and HLA-DR (clone
BRA-30, IgG2a) (all from Neomarkers, Fremont, Calif.) and isotype-matched
control antibodies (Chemicon International, Inc., Temecula, Calif.). No preser-
vatives were contained in any of the monoclonal antibodies. The monoclonal
antibodies were added to cultures at a final concentration of 10 g/ml. Cultures
were then incubated in the presence of human hsp60 for 6 days, pulsed, and
harvested as described for the proliferation assay.
RNA separation and cDNA synthesis. Cultures were also set up for single-
strand conformation polymorphism (SSCP) analysis of the TCR -chain and for
cytokine mRNA expression. Cells were cultured at a concentration of 106/well in
a 24-well culture plate (Corning Inc., Corning, N.Y.) as for the proliferation
assay. Total RNAs from gingival tissues and PBMC were separated by using
Isogen (Nippon Gene, Tokyo, Japan) according to the manufacturer’s instruc-
tions. The RNA samples were further purified by successive treatment with
DNase I (GIBCO BRL, Gaithersburg, Md.), phenol-chloroform-isoamyl alcohol
(GIBCO BRL), and ethanol sedimentation.
The first-strand cDNA was synthesized using Moloney murine leukemia virus
reverse transcriptase (GIBCO BRL) and 50 M random hexanucleotides
(Takara Shuzo Co., Ltd., Shiga, Japan) from 2 g of total RNA in a reaction
buffer (GIBCO BRL) containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, and 3
mM MgCl2, supplemented with 0.5 U of RNase inhibitor, 0.1 M dithiothreitol,
and deoxynucleoside triphosphates (dNTP) (each at 0.5 mM). The reaction
mixture was incubated at 37°C for 60 min and then heated at 95°C for 5 min.
SSCP analysis. PCR utilizing the 22 V family-specific 5	 primers coupled
with the common C 3	 primer designed by Choi et al. (7) was performed with
2.5 U of Taq DNA polymerase (Takara) in a final volume of 15 l containing 6
pmol of each primer, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2,
0.01% gelatin, and dNTP (each at 0.2 mM) in an automated DNA thermal cycler
(PCR Thermal Cycler MP; Takara). The amplification cycle profile was as
follows: denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and
extension at 72°C for 1 min. The durations of denaturation in the first cycle and
extension in the last cycle were extended for 7 min. After 35 cycles of amplifi-
cation, the amplified DNA was diluted (1:39) in a denaturing solution (95%
formamide, 10 mM EDTA, 0.1% bromophenol blue, 0.1% xylenecyanol) and
kept at 90°C for 2 min. The diluted samples (2 l) were electrophoresed in
nondenaturing 4% polyacrylamide gels containing 10% glycerol. Gels were run
at a constant power of 35 W for 100 min. After electrophoresis, the DNA was
transferred to Immobilon-S membranes (Millipore Intertech, Bedford, Mass.)
and visualized after incubations with a biotinylated C probe [5	-A(A/C)AA(G
/C)GTGTTCCCACCCGAGGTCG-CTGTGTT-3	], streptavidin, biotinylated
alkaline phosphatase, and a chemiluminescent substrate system (Phototope de-
tection kit; New England Biolabs, Inc., Beverly, Mass.).
Sequence analysis. In order to compare the nucleotide sequences of the CDR3
regions of hsp60-stimulated PBMC, P. gingivalis GroEL-stimulated PBMC, and
gingival-tissue derived T cells, DNA was extracted from the small area of the
SSCP gel corresponding to the bands demonstrating identical electrophoretic
mobility. Extracted DNA was reamplified and purified by agarose gel electro-
phoresis followed by a DNA purification kit. The recovered DNA fragments
were subcloned into pCR 2.1 and transfected into TOP10F	 (Invitrogen Co., San
Diego, Calif.). After blue/white screening of recombinant plasmids on a 5-bro-
mo-4-chloro-3-indolyl--D-galactoside indicator plate, single white colonies were
picked and grown for 12 h at 37°C in Luria-Bertani (LB) broth. After plasmid
purification, the correct inserts in positive clones were confirmed by PCR am-
plification with the respective V and common C primers and were then used
for automated sequencing (Pharmacia Biotech, Uppsala, Sweden).
Determination of IFN- and IL-4 concentrations in culture supernatant.
After incubation, culture supernatants were removed, aliquoted, and stored at
80°C until analysis for IFN- and IL-4 levels with commercially available
enzyme-linked immunosorbent assay (ELISA) kits (Immunotech, Marseille,
France).
PCR amplification of IFN- and IL-4 genes. cDNA was PCR amplified by
using oligonucleotide primers specific for IFN- (5	-ATGTAGCGGATAATG
GAATCT-3	 and 5	-AACTTGACATTCATGTCTTCC-3	) and IL-4 (5	-ACTG
CAAATCGACACCTATTA-3	 and 5	-ATGGTGGCTGTAGAACTGC-3	).
PCR amplification was performed in a final volume of 15 l containing 1.2 l of
cDNA, 0.35 U of Taq DNA polymerase (Takara), 6 pmol of each primer, 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.01% gelatin, and dNTP (each
at 0.2 mM) in an automated DNA thermal cycler (Takara). The amplification
cycle profile was as follows: denaturation at 94°C for 10 s, annealing at 60°C for
20 s, and extension at 72°C for 30 s. The durations of denaturation in the first
cycle and extension in the last cycle were extended for 7 min. After 30 and 35
cycles of amplification for IFN- and IL-4, respectively, each PCR product was
electrophoresed on a 2% agarose gel, visualized by ethidium bromide staining,
and photographed.
Image analysis of cytokine mRNA expression. The gels were photographed,
and their image data were analyzed by using NIH Image (version 1.62) computer
software. In order to improve the accuracy of the analysis, the ratio of the gene
expression level of each cytokine to that of the -actin gene was calculated.
Briefly, by using Gel Plotting Macros, the total areas of bands of each lane on the
gel were calculated. The expression of each cytokine gene relative to that of
-actin was compared between stimulations with human hsp60 and P. gingivalis
GroEL.
Statistical analysis. The proliferative responses and the levels of either cyto-
kine mRNA expression or protein production of PBMC stimulated with human
hsp60 and P. gingivalis GroEL were compared. The differences were compared
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by using an unpaired t test. A probability value of 0.05 was considered statis-
tically significant.
RESULTS
Proliferative responses of PBMC to hsp60 and P. gingivalis
GroEL. Figure 1 shows the proliferative responses of PBMC
from periodontally healthy subjects and periodontitis patients
to recombinant human hsp60 and P. gingivalis GroEL. There
was no significant difference between control subjects and pa-
tients in the baseline response (without stimulation). However,
the PBMC from periodontitis patients demonstrated a marked
mean proliferative response to human hsp60 4 times greater
than that of PBMC from control subjects. This difference was
statistically significant (P 
 0.015). However, P. gingivalis
GroEL did not induce significant proliferative responses in
periodontitis patients or in control subjects. We have checked
the endotoxin contamination level in the human hsp60 (unde-
tectable) and recombinant P. gingivalis GroEL (12.5 pg/ml)
prepared in our laboratory by a Limulus test (Endospecy;
Seikagaku Corporation, Tokyo, Japan). These results clearly
suggest that T cells proliferated in response to human hsp60
protein but not in response to contaminating endotoxin in the
antigen preparation. This is further supported by the fact that
P. gingivalis GroEL, which contains a trace amount of endo-
toxin, did not induce significant proliferation. Thus, it is con-
cluded that the human hsp60 stimulated T cells of periodontitis
patients specifically.
MHC restriction. To investigate the MHC restriction of the
proliferative response to human hsp60, we tested the effect of
anti-HLA-DP, anti-HLA-DQ, and anti-HLA-DR monoclonal
antibodies or isotype-matched controls (Fig. 2). The data
showed that HLA-DR molecules could function as restricting
elements. These results again clearly indicate that the T-cell
response to human hsp60 in periodontitis patients is antigen
specific.
Cytokine expression in response to hsp60 and P. gingivalis
GroEL. Expression of IFN- and IL-4 in response to human
hsp60 and P. gingivalis GroEL was examined at both the
mRNA and protein levels. As shown in Fig. 3A, there was no
significant difference between the control group and periodon-
titis patients in the spontaneous expression of IFN- mRNA.
However, there was a significant up-regulation of mRNA ex-
pression with hsp60 stimulation in periodontitis patients but
not in control subjects (P 
 0.02). P. gingivalis GroEL had no
or little effect on IFN- mRNA expression in PBMC for con-
trol subjects or periodontitis patients, respectively. As shown in
Fig. 3B, IFN- was almost undetectable in the culture super-
natants of control subjects irrespective of the presence or ab-
sence of stimulants. In periodontitis patients, IFN- produc-
tion tended to be higher than in control subjects in the absence
of stimulants. On the other hand, human hsp60 induced sig-
nificantly higher production of IFN- in periodontitis patients
but not in control subjects. P. gingivalis GroEL had no effect on
IFN- production in either control subjects or periodontitis
patients.
For IL-4, both human hsp60 and P. gingivalis GroEL tended
to increase mRNA expression in healthy subjects. However,
the effects were not significant. In contrast to IFN-, there was
no significant difference in IL-4 mRNA expression in peri-
odontitis patients between unstimulated and stimulated cul-
tures (Fig. 4A).
It was interesting that down-regulation of IL-4 production
was observed in periodontitis patients without stimulation.
Furthermore, there was no stimulatory effect of human hsp60
or P. gingivalis GroEL on IL-4 production in periodontitis
patients. IL-4 production in periodontitis patients remained at
low levels irrespective of the culture conditions. Although P.
gingivalis GroEL tended to down-regulate IL-4 production in
control subjects, this effect was not statistically significant (Fig.
4B).
Effects of human hsp60 and P. gingivalis GroEL on periph-
eral blood T-cell clonality and T-cell clonality in gingival tis-
FIG. 2. Inhibition of proliferation by class-specific anti-MHC
monoclonal antibodies. PBMC from a patient demonstrating a positive
proliferative response to human hsp60 were incubated at a concentra-
tion of 3  105/ml with 10 g of human hsp60/ml in the presence or
absence of monoclonal antibodies recognizing different MHC class II
gene products for 6 days. Isotype-matched control antibodies were also
included. Data are expressed in mean counts per minute  standard
errors of triplicate cultures.
FIG. 1. Proliferative responses to human hsp60 and P. gingivalis
GroEL by PBMC from periodontitis patients and control subjects.
PBMC at a concentration of 3  105/ml were cultured either alone or
with 10 g of human hsp60 or P. gingivalis GroEL/ml for 6 days. Data
are expressed as mean counts per minute  standard errors for either
periodontitis patients (n 
 16) or control subjects (n 
 10). , signif-
icantly higher in periodontitis patients than in control subjects.
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sue. Stimulation with human hsp60 and P. gingivalis GroEL
demonstrated distinctive effects on the T-cell clonalities of
periodontitis patients and control subjects. Although unstimu-
lated T cells demonstrated smear patterns with a few bands in
both periodontitis patients and control subjects (Fig. 5Aa and
Ba), a number of distinct bands appeared after stimulation
with human hsp60 or P. gingivalis GroEL in periodontitis pa-
tients (Fig. 5Ab and Bc). However, in most of the control
subjects, clonal accumulation of T cells was hardly observed
following stimulation (Fig. 5Ab and Ac). These results indicate
that human hsp60 and P. gingivalis GroEL induced clonal ex-
pansion in an antigen-specific manner in periodontitis patients
preferentially. Furthermore, the emergence of new distinct
bands was observed more often in human hsp60-stimulated
cultures than in P. gingivalis GroEL-stimulated cultures and
was not restricted to particular V families across the patients
(Table 1). On the other hand, T cells in gingival tissues dem-
onstrated obvious clonal accumulation, as evidenced by a num-
ber of distinct bands in both control subjects (Fig. 5Ad) and
periodontitis patients (Fig. 5Bd).
In some cases, identical T-cell clones appeared to be ex-
panded by stimulation with human hsp60 and P. gingivalis
GroEL, as the positions of some of the newly emerged bands
seemed to be identical with the different stimuli. Moreover,
these T-cell clones seemed to exist in the gingival tissues. This
assumption is derived from the principle of SSCP analysis that
the electrophoretic mobilities of the denatured single-strand
DNA fragments can be determined by their nucleotide se-
FIG. 3. Effects of human hsp60 and P. gingivalis GroEL on the expression of mRNA (A) and protein (B) of IFN- by PBMC in periodontitis
patients and control subjects. PBMC were stimulated with 10 g of human hsp60 or P. gingivalis GroEL/ml for 6 days. The intensity of cytokine
gene expression was calculated relative to the intensity of -actin gene expression as a control. Cytokine levels in the culture supernatants were
determined by using an ELISA kit according to the manufacturer’s instructions. Data are expressed as means  standard errors for either
periodontitis patients (n 
 16) or control subjects (n 
 10). , significantly higher in periodontitis patients than in control subjects.
FIG. 4. Effects of human hsp60 and P. gingivalis GroEL on expression of mRNA (A) and protein (B) of IL-4 by PBMC in periodontitis patients
and control subjects. PBMC were stimulated with 10 g of human hsp60 or P. gingivalis GroEL/ml for 6 days. The intensity of cytokine gene
expression was calculated relative to the intensity of -actin gene expression as a control. Cytokine levels in the culture supernatants were
determined by using an ELISA kit according to the manufacturer’s instructions. Data are expressed as means  standard errors for either
periodontitis patients (n 
 16) or control subjects (n 
 10). No significant difference was observed between periodontitis patients and control
subjects irrespective of the presence or absence of stimulation.
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FIG. 5. T-cell clonalities of PBMC with or without stimulation either human hsp60 or P. gingivalis GroEL in a control subject (A) and a
periodontitis patient (B). Gingival tissue of periodontitis lesions from the periodontitis patient was analyzed simultaneously. PCR products
encoding TCR V genes from PBMC and gingival tissue were analyzed by the SSCP method as described in Materials and Methods. (a)
Unstimulated PBMC; (b) Human hsp60-stimulated PBMC; (c) P. gingivalis-stimulated PBMC; (d) Gingival tissue. Each lane represents a
particular V family.
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TABLE 1. Numbers of distinct bands emerging in PBMC from periodontitis patients and control subjects after stimulation
with hsp60 on P. gingivalis GroEL
Group and
subject Stimulant
No. of distinct bands for V gene family Total no.
of bands1 2 3 4 5.1 5.2 6 7 8 9 10 11 12 13.1 13.2 14 15 16 17 18 19 20
Periodontitis
P2 Hsp60 0 0 0 0 0 0 1 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 4
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
P3 Hsp60 1 0 1 0 2 0 0 0 0 0 0 0 0 1 0 2 1 0 0 0 0 1 9
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
P4 Hsp60 0 0 1 1 2 2 4 0 3 0 1 0 1 1 0 1 1 0 1 0 0 1 20
P. gingivalis GroEL 0 0 1 0 0 1 1 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 6
P5 Hsp60 0 0 1 0 0 0 0 1 0 1 2 0 0 2 0 0 0 0 0 0 0 0 7
P. gingivalis GroEL 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 2
P6 Hsp60 0 0 1 0 1 2 1 0 1 0 1 1 2 0 0 0 1 0 0 1 0 0 12
P. gingivalis GroEL 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2
P7 Hsp60 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 1 4
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
P8 Hsp60 1 1 0 0 2 0 1 0 0 2 0 0 0 0 0 2 0 1 0 1 0 1 12
P. gingivalis GroEL 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2
P9 Hsp60 0 2 2 0 0 0 2 0 1 0 1 2 0 0 4 7 0 0 0 0 0 3 24
P. gingivalis GroEL 0 1 0 0 2 1 2 0 1 3 0 0 0 2 0 7 1 0 0 0 0 3 23
P10 Hsp60 0 0 2 1 0 0 1 1 0 1 2 0 1 0 0 0 0 0 0 0 0 3 12
P. gingivalis GroEL 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 3
P11 Hsp60 0 0 0 0 1 0 0 1 0 0 1 0 0 0 0 3 0 0 0 2 1 5 14
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 1 0 4 8
P12 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 2
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 0 2 1 6
P13 Hsp60 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 2 0 0 0 1 0 0 7
P. gingivalis GroEL 0 0 0 0 2 0 0 0 0 2 2 0 0 0 0 2 3 0 0 1 0 3 15
P14 Hsp60 0 0 0 0 4 0 0 0 3 3 0 0 0 1 0 0 0 0 0 0 0 0 11
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 1 0 0 3
P15 Hsp60 0 2 1 0 0 1 0 0 0 0 1 0 0 1 0 0 1 0 0 0 0 2 9
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
P16 Hsp60 0 2 0 1 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 1 7
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Mean Hsp60 10.3
P. gingivalis GroEL 4.7
Control
C1 Hsp60 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
P. gingivalis GroEL 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 4
C2 Hsp60 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 3
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 2
C3 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 2
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1
C4 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
P. gingivalis GroEL 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 3
C5 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Continued on following page
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quences. Therefore, DNA fragments derived from T-cell
clones bearing identical TCR -chains would show identical
electrophoretic mobilities on an SSCP gel. In order to confirm
this, PCR products for the expected V family prepared from
samples stimulated with human hsp60 and/or P. gingivalis
GroEL and from gingival-tissue-derievd samples were applied
to adjacent lanes on the same SSCP gel only when there
seemed to be distinct bands showing identical electrophoretic
mobilities. However, if the position of a band that had newly
emerged following stimulation of peripheral blood was appar-
ently different from the position of a distinct band in the
autologous gingival samples, this procedure was not carried
out. As shown in Fig. 6, SSCP analysis of the expected V
family clearly demonstrated that peripheral blood samples
stimulated with human hsp60, peripheral blood samples stim-
ulated with P. gingivalis GroEL, and gingival tissue samples
showed identical electrophoretic mobilities. For patients P5
and P8, identical T-cell clones were found in human hsp60-
stimulated PBMC, P. gingivalis GroEL-stimulated PBMC, and
the periodontitis lesion. Identical T-cell clones were found only
in hsp60-stimulated PBMC and the periodontitis lesion for
patients P1 and P3.
Sequence analysis of the junctional region of expanded T-
cell clones following stimulation and of clones accumulated in
periodontitis lesions. We further analyzed the nucleotide se-
quences within the VDJ junctional regions of the clones sus-
pected of having identical TCR -chains. A small piece of the
gel corresponding to the band was cut, and the extracted DNA
was subjected to PCR amplification. In order to avoid cross-
contamination, each band was cut from a different gel.
As shown in Table 2, clones which had identical electro-
phoretic mobilities on the SSCP gel demonstrated identical
sequences within the junctional regions, confirming that hu-
man hsp60 and P. gingivalis GroEL induced expansion of the
same T-cell clones in some patients. Moreover, those T-cell
clones accumulated in the inflamed gingival lesions of peri-
odontitis patients. Identical clones were also found in human
hsp60-stimulated PBMC and the periodontitis lesion but not in
P. gingivalis GroEL-stimulated PBMC for some patients. In
contrast, the same T-cell clone in P. gingivalis GroEL-stimu-
lated PBMC and the periodontitis lesion was seen for patient
P9. These results clearly indicate that human hsp60-reactive T
cells that also cross-react with P. gingivalis GroEL account for
at least part of the infiltrating T cells in periodontitis lesions.
DISCUSSION
Periodontitis is a chronic inflammatory disease caused by a
group of gram-negative bacteria. Despite the fact that a num-
ber of so-called periodontopathic bacteria are believed to be
involved in the initiation and progression of the disease, our
recent study has clearly demonstrated that the T cells infiltrat-
ing lesions recognize only a restricted number of antigens or
epitopes (41). Due to their high conservation among various
TABLE 1—Continued
Group and
subject Stimulant
No. of distinct bands for V gene family Total no.
of bands1 2 3 4 5.1 5.2 6 7 8 9 10 11 12 13.1 13.2 14 15 16 17 18 19 20
C6 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
C7 Hsp60 0 0 1 0 2 0 0 0 0 0 1 0 0 0 0 2 1 1 0 2 0 0 10
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 2
C8 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 2
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
C9 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1
P. gingivalis GroEL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
C10 Hsp60 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 2
P. gingivalis GroEL 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 3
Mean Hsp60 2.3
P. gingivalis GroEL 1.5
a Numbers indicate the difference in the number of TCR clonotypes for each V gene between unstimulated and stimulated PBMC. Unstimulated PBMC from
patient P1 were not analyzed.
FIG. 6. Demonstration of common TCRs in PBMC stimulated
with hsp’s and gingival tissue from the periodontitis patient. PCR
products encoding TCR V genes from PBMC and gingival tissue
were analyzed by the SSCP method as described in Materials and
Methods. Arrowheads indicate identical clones. Tissue, gingival tissue-
derived T-cell clones; Hsp60, hsp60-stimulated PBMC; Pg GroEL, P.
gingivalis GroEL-stimulated PBMC.
2498 YAMAZAKI ET AL. INFECT. IMMUN.
 o
n
 O
ctober 20, 2015 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
microbial pathogens and their ability to induce very strong
cellular and humoral immune responses, hsp60s have been
suggested as possible candidate antigens in periodontitis. Re-
cently, we demonstrated that self-hsp60 might also be a target
for autoimmune responses in periodontitis due to its molecular
mimicry of the bacterial homologue GroEL (29). This led us to
investigate T-cell responses to human hsp60 and P. gingivalis
GroEL in periodontitis patients.
In the present study we clearly demonstrated a strong pro-
liferative T-cell response to human hsp60 in periodontitis pa-
tients compared with periodontally healthy control subjects. In
order to exclude the possibility that contaminating endotoxins
in the recombinant protein could be inducing this T-cell re-
sponse, we determined endotoxin levels in human hsp60 and P.
gingivalis GroEL. While P. gingivalis GroEL contained 12.5 pg
of endotoxins/ml, no endotoxins were found in human hsp60. If
the T-cell response in the present study were caused by con-
taminating endotoxins, P. gingivalis GroEL would be more
stimulatory than human hsp60. Furthermore, the proliferative
response to human hsp60 was inhibited by anti-MHC class II
antibodies. Thus, we conclude that the elevated T-cell re-
sponse to human hsp60 in periodontitis patients is antigen
specific.
In the present study the proliferative response to P. gingivalis
GroEL was much lower than that to human hsp60. In contrast,
the proliferative response of PBMC to mycobacterial hsp65
was higher than that to human hsp60 in rheumatoid arthritis
patients (18). The reasons for this observation are as yet un-
known. It could be speculated that because periodontopathic
bacteria almost always reside in periodontal pockets (i.e., out-
side of the body), the immune system may not be effective in
eradicating the infection. Instead, the continuous insult by
pathogenic substances, including bacterial hsp60, may over-
stimulate T cells, which, in turn, may induce anergy. Alterna-
tively, P. gingivalis GroEL may stimulate regulatory T cells (Tr
cells), which play a critical role in the generation and mainte-
nance of tolerance. Under normal conditions, potentially self-
reactive T cells in the periphery are effectively controlled by
different mechanisms leading to peripheral tolerance (8, 14,
27). In some models, down-regulation of the TCR in response
to continuous challenge with self-antigen maintains tolerance
among peripheral T cells (8, 27). Recent findings suggest that
Tr cells are enriched within the CD4 CD25 subset (4, 30,
32) and that the function of Tr cells is crucially dependent on
signaling via cytotoxic T-lymphocyte-associated antigen 4
(CTLA-4), which was found to be constitutively expressed on
these cells (24, 25, 31). In this respect, Aoyagi et al. demon-
strated that stimulation of PBMC with P. gingivalis antigen
induced concomitant elevation of CD25 expression and
CTLA-4 expression within the CD4 subset in periodontitis
patients (3).
The immunogenicity of P. gingivalis GroEL may not be as
strong as that of human hsp60. However, because of the higher
homology of P. gingivalis GroEL with other periodontopathic
bacteria-derived GroELs than with human hsp60 (11), levels of
antibody to P. gingivalis GroEL in periodontitis patients are
elevated and maintained partially by the mechanism of molec-
ular mimicry.
Cross-reactive T-cell responses against hsp’s from bacteria
and the host have been found in a number of studies (1, 17, 20,
23). These studies usually used synthetic peptides as antigens.
In the present study, experiments were performed to evaluate
TABLE 2. Amino acid sequences of the common TCR V genes from T cells in gingival tissues and hsp60- and
P. gingivalis GroEL-stimulated PBMC in periodontitis patients
Patient (V family) and sample
Amino acid sequencea
J Frequency
V N-D-N
P1 (V 16)
Gingiva CASS RTLQ 2.5 4/17
hsp60-stimulated PBMC CASS RTLQ 2.5 3/17
P3 (V 13.1)
Gingiva CASS YSTGTGS 1.1 4/7
hsp60-stimulated PBMC CASS YSTGTGS 1.1 3/11
P5 (V 9)
Gingiva CASS QERLAGPP 2.2 3/4
hsp60-stimulated PBMC CASS QERLAGPP 2.2 2/6
P. gingivalis GroEL-stimulated PBMC CASS QERLAGPP 2.2 3/18
P6 (V 6)
Gingiva CASS SGLNR 2.7 4/5
hsp60-stimulated PBMC CASS SGLNR 2.7 3/4
P8 (V 16)
Gingiva CASS HARD 2.4 7/33
hsp60-stimulated PBMC CASS HARD 2.4 2/20
P. gingivalis GroEL-stimulated PBMC CASS HARD 2.4 2/24
P9 (V 8)
Gingiva CASS APGTAF 1.5 3/28
P. gingivalis GroEL-stimulated PBMC CASS APGTAF 1.5 3/30
P9 (V 8)
Gingiva CA IRPS 2.3 2/28
hsp60-stimulated PBMC CASS RPSG 2.7 4/24
P. gingivalis GroEL-stimulated PBMC CASS RPSG 2.7 2/30
a Junctional sequences of TCR V genes, which were commonly found in gingival tissues and hsp60-stimulated and P. gingivalis GroEL-stimulated PBMC from
patients whose SSCP gels are presented in Fig. 5.
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whether physiologic processing generates self-epitopes pre-
sented by host cells to cross-reactive T cells specific for micro-
bial hsp60. To this end, we employed reverse transcriptase
PCR-SSCP analysis. SSCP analysis has the advantage of iden-
tifying the expansion of the reactive T-cell population, with the
expanded T-cell clones detected by the emergence of distinct
bands on the gel (39). Furthermore, T-cell clones using the
same V gene but different CDR3 regions can be distinguished
by different positions of the bands. Expansion of T-cell clones
reactive to human hsp60 and P. gingivalis GroEL was observed
more often in periodontitis patients than in control subjects, as
demonstrated by SSCP analysis with a higher frequency for
human hsp60-reactive T cells. The latter result is consistent
with the higher proliferative response to hsp60 in periodontitis
patients but is inconsistent with the theory that cross-reactive
T-cell epitopes shared by pathogen and host may induce au-
toimmune phenomena (34), since the number of T-cell clones
reactive to P. gingivalis GroEL was smaller than the number
responsive to human hsp60. As a well-balanced network of
potentially self-reactive T cells that have evaded deletion pro-
cesses exists in healthy individuals, activation of self-hsp60-
reactive T cells seems to occur preferentially during inflamma-
tory responses (1). In support of this concept, we demonstrated
that the number of T-cell clones reactive to both human hsp60
and P. gingivalis GroEL was very small in control subjects.
Petit et al. (22) reported a lower proliferative response to
human hsp60 in periodontitis patients than in gingivitis pa-
tients and speculated that this poor reactivity to hsp’s may be
a susceptibility factor for destructive periodontal disease. They
also examined the cytokine profile following stimulation with
hsp60 and demonstrated that the level of IFN- production
was significantly lower in the periodontitis group than in the
control group. In the present study, however, hsp60 signifi-
cantly stimulated IFN- production in periodontitis patients,
suggesting that the proliferative responses to human hsp60 are
probably a selective stimulation of specific T cells with a type 1
cytokine profile. Although the precise reason is not known, the
contradiction between these two results may come from dif-
ferences in the source of PBMC, i.e., differences with regard to
particular patients’ race, severity of the disease, and age. De-
tails of clinical assessment were not given in their report; how-
ever, it can be considered that disease severity and age were
higher for our patients than for their patients.
It has been demonstrated that eukaryotic hsp60 enhanced
and accelerated antigen-specific IFN- secretion of CD4 T
cells undergoing primary stimulation and that the IFN- pro-
duction depended strictly on the IL-12 that was produced by
antigen-presenting cells (6). Since we confirmed the stimula-
tory effect of human hsp60 but not that of P. gingivalis GroEL
on macrophages by measuring tumor necrosis factor alpha
production, the Th1 stimulation ability observed in our study
could have been at least in part due to IL-12 produced by
monocytes in the culture (33). There is evidence of production
of both Th1 and Th2 cytokines in periodontitis lesions (9, 40),
and a subtle imbalance in the cytokine profile may induce
tissue destruction. Therefore, up-regulation of hsp60 expres-
sion in gingival lesions during the immune reaction to peri-
odontopathic bacteria may induce Th1 polarization.
The role of the immune response to hsp60 in infectious
diseases and autoimmune diseases is still controversial. In
rheumatoid arthritis, a protective role for hsp60-specific T cells
has been suggested. This is thought to occur as a result of
stimulation of suppressive T-cell responses (36) and mainte-
nance of regulatory T-cell networks (35). Although the role of
hsp60-reactive T cells in periodontitis remains to be deter-
mined, an elevated proliferative response may also be indica-
tive of subsequent disease remission. Alternatively, it is con-
ceivable that hsp60-specific T cells may be involved in tissue
destruction via the production of macrophage proinflamma-
tory cytokines and other mediators such as prostaglandin E2
(10). Finally, the reason for the higher reactivity to hsp60 in
periodontitis patients remains unknown. Further studies are
required to elucidate the role of hsp60-specific T cells in
chronic inflammations such as periodontitis.
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